Navigation Links
Lead Plaintiff's Attorney In Forest Pharmaceuticals Case Says $313 Million Award Is 'Tip of the Iceberg' of Future Off-Label Marketing Lawsuits
Date:9/17/2010

SHORT HILLS, N.J., Sept. 17 /PRNewswire/ -- Fresh off his victory for a whistle-blower in the Forest Pharmaceuticals, Inc. lawsuit, attorney David Stone is setting his sights on the billions of dollars of settlements he expects awarded in future legal actions involving off-labeling marketing practices.

"The award of $313 million in the Forest Pharmaceuticals case is just the tip of the iceberg in comparison to the amount of off-label marketing kick-back settlements we'll see in the future," Stone said. "Pharmaceutical companies are under increasing competitive pressures. Unfortunately, in their attempts to increase product sales, many are engaging in deceptive and illegal conduct, which has endangered patients' health and even their lives, as well as cost taxpayers billions of healthcare dollars."

Stone, managing partner of Short Hills, NJ-based law firm Stone & Magnanini LLP, represented a physician who originally brought Forest Pharmaceuticals' illegal marketing practices to the government's attention in a 2001 False Claims Act lawsuit. Stone previously served as head of the False Claims Act department for renowned litigator, David Boies, and headed that firm's New Jersey office.

Stone explained that the Federal government is focusing more broadly on pharmaceutical industry marketing practices. The Department of Justice and the Office of the Inspector General are scrutinizing practices tied to relations between drug makers and the physicians who endorse their products; the content and distribution of product promotional materials; and the complex inter-relationship of manufacturers, physicians, insurers and others in the drug-delivery chain.

Forest Pharmaceuticals recently agreed to settle civil and criminal claims based on off-label marketing and kick-backs to physicians for the antidepressant drugs Celexa and Lexapro, and Levothoid, a drug used to treat hypothyroidism, for more than $313 million.  

Stone & Magna
'/>"/>

SOURCE Stone & Magnanini LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Plaintiffs and Novartis Pharmaceuticals Corporation, a US Subsidiary of Novartis AG, Agree to Resolve All Gender Discrimination Claims Associated With Class Action
2. Fort Worth Attorney Dwain Dent Comments on Final Judgment in Case That Left Hundreds of Babies Dead or Injured
3. Remarks as Prepared for Delivery By Attorney General Eric Holder at the AstraZeneca Settlement Announcement
4. Relators Attorneys Comment On AtriCure/DOJ Proposed Settlement
5. Whistleblowers Attorney Says Pfizers Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies
6. Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws
9. NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood
10. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
11. Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)...  Sequence, Inc., an industry leader in the field of ... manufacturers is opening a third office location in the "Gateway ... a result of demand by clients to provide cost effective ... allows Sequence to better serve new and existing customers in ... office provides Sequence a hub to support customers ...
(Date:8/19/2014)... Aug. 19, 2014 Research and Markets ... Global Strategic Business Report" report to their offering. ... Products in US$ Thousands by the following three major Application ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ...
(Date:8/18/2014)... NAGOYA, Japan , Aug. 19, 2014 ... ASAHI INTECC (Securities Code 7747, Second Section, ... plans to develop a new, differentiated fractional flow reserve ... device intended to improve handling compared to existing FFR ... field in interventional cardiology that exceeds $250 million worldwide ...
Breaking Medicine Technology:Quality and Compliance Solutions Provider Announces Opening of St. Louis, Missouri Office 2Global Anti-Adhesion Products - Strategic Business Report 2014 2Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 2Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 3Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 4
... results of the Spare the,Nephron (STN) study, ... protocol using CellCept(R) (mycophenolate,mofetil), showed the CellCept-based ... with improved renal function when compared with ... (CNI)., Furthermore, the study showed this ...
... Clinical Phase 2 data presented at American Society of Clinical ... ... MEDX ) today announced updated long-term follow-up and overall,survival (OS) ... ipilimumab in combination with dacarbazine (DTIC) where 11.4%, or 4 of,35 ...
Cached Medicine Technology:Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 2Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 3Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 4Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 5Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 2Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 3Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 4
(Date:8/20/2014)... The “Human Insulin Market by ... Premixed), Modern Human Insulin (Rapid Acting, Long Acting, ... Tresiba, Others) - Forecast to 2019” provides a ... current market trends,and strategies impacting the global human ... of the revenue and share analysis. , Browse ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 GBK, the luxury ... 2014 Emmy Award Nominees and Presenters at the annual GBK ... 22nd and 23rd in Beverly Hills from 11am – 6pm. ... and music by DJ Morgan Hildebrand. , As always, GBK ... will feature several charities at the lounge. GO Campaign is ...
(Date:8/20/2014)... VA (PRWEB) August 20, 2014 What ... by Getting Locked Out of the Market, **FDAnews Webinar**, ... EDT, http://www.fdanews.com/DoNowforUDI , Hospitals and other buyers ... due to ineffective product tracking systems. , Complying with ... is customer demands to implement UDI as soon as ...
(Date:8/19/2014)... The elegant bamboo floorings from BambooIndustry.com ... houses in an environmentally conscious way with the company’s ... and have an aluminum oxide finish to help resist ... high-traffic areas. , Recently, the company has released its ... . These fresh items are specially made for global ...
(Date:8/19/2014)... 2014 For decades it has been ... chiropractic adjustments are dangerous and cause strokes, cervical artery ... they do not recommend chiropractic to their patients. Now ... do refer to chiropractors because they have read the ... new research has popped up that tries to cast ...
Breaking Medicine News(10 mins):Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 2Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 4Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 2Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 3Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 4Health News:BambooIndustry.com Announces Up To 30% Discount On Its New Click Strand Woven Bamboo Floorings 2Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 2Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 3Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 4
... Penn Avenue Place buildings participate in World ... Wildlife Fund,s (WWF) Earth Hour, PITTSBURGH, ... Place and Penn Avenue Place facilities,will go dark from 8 to ... companies around the world in the World Wildlife Fund,s,(WWF) Earth Hour ...
... quick laugh and easy smile of a woman who continues ... She still works every day in the family business, heads ... for her energetic grandchildren. , This winter when the ... third time, her oncologist prescribed a new breed of targeted ...
... March 27 The Men,s Health Policy,Center, a ... Network,(MHN), announced today that they are hosting an ... Medicare and Medicaid Services (CMS) practice,that unfairly restricts ... "This petition allows people who are impacted by ...
... New Poll: Teens Still Feel Targeted By Tobacco Advertising ... 27 Kids across D.C. will,rally against tobacco on ... for the 13th annual Kick Butts Day, sponsored by ... across the nation,(for a list of local events, go ...
... The Richard B. and,Lynne V. Cheney Cardiovascular ... have joined the Institute,s Board of Directors. As ... Institute., "Mary Matalin,s experience in public affairs ... Institute as we build our organization and educate,communities ...
... March 27 Clarient, Inc.,(Nasdaq: CLRT ), a ... pharmaceutical industry, today announced,that it is scheduled to make ... Annual Las Vegas Investor Conference at 4:00 p.m. PDT ... is being held at the Palms,Casino Resort April 2-4, ...
Cached Medicine News:Health News:Highmark, Prominent Part of Pittsburgh City Skyline, to Go Dark for One Hour to Support the Environment 2Health News:Saving cancer patients' skin 2Health News:Saving cancer patients' skin 3Health News:Men's Health Policy Center Hosts Petition to Protest Government Barrier to Prostate Cancer Medications 2Health News:D.C. Kids 'Kick Butts' on April 2 2Health News:D.C. Kids 'Kick Butts' on April 2 3Health News:Mary Matalin and John Ray Join the Cheney Cardiovascular Institute Board of Directors 2Health News:Clarient to Present at the B. Riley & Co. 9th Annual Las Vegas Investor Conference 2
... iMRI is a neurosurgical OR that ... diagnostic tools, including iMRI, necessary to ... iMRI, neurosurgical treatments are performed in ... designed for MR compatibility and safety, ...
... Neuropack M1 is an advanced ... system. It is a sophisticated 2 ... MEB-2200. 2 electrical stimulations, 2 sound ... goggles stimulation. You can customize each ...
Every so often a new product comes along that isn't a small step but a giant leap ahead of everything that has preceeded it. Such is the impact of the Fidelity IAB....
... Dimension cardiovascular ultrasound system is the world's ... fully integrated real-time 4D and multi-dimensional imaging ... member of the Vivid 7 family, provides ... diagnosing heart conditions such as heart failure ...
Medicine Products: